drugset / Trial / NCT01302119

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

NCT01302119

Phase 3 Completed 604 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Timeline

Start
2011-02
Primary completion
2012-12-31
Completion
2013-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Tavaborole Small molecule 5 % Topical